SureTrader Nadex Advertisement
Home > Boards > US OTC > Biotechs >

Amarantus Bioscience Holdings Inc. (AMBS)

AMBS RSS Feed
Add AMBS Price Alert      Hide Sticky   Hide Intro
Moderator: JPetroInc, zoomboom
Search This Board: 
Last Post: 2/24/2017 2:07:01 PM - Followers: 702 - Board type: Free - Posts Today: 4

 

(AMBS) Amarantus BioScience Holdings, Inc. 

Amarantus is a biotechnology company developing treatments and diagnostics for diseases associated with neurodegeneration and protein misfolding-related apoptosis.
The company has licensed Eltoprazine, a Phase 3 ready Parkinsons Levadopa induced Dyskinesia.

 (MANF) is a human growth factor that plays a key role in the prevention of apoptosis (cell death). It is being developed for the potential treatment of RP, Parkinson's disease, Wolfram syndrome, diabetes, Alzheimer's disease and traumatic brain injury.

ESS, previously known as PermaDerm®  is being developed to be the only tissue-engineered skin prepared from autologous (patient's own) skin cells consisting of both epidermal and dermal layers. A small harvested section of the patient's own skin can be grown to graft an area one hundred times its size in as little as thirty days. 
For further information, please visit www.Amarantus.com, or connect with the company in FacebookTwitter, LinkedIn & Google+
 
                                                                                       


 

NEWS



Bio-engineering skin to treat severe burns
 
 

   Videos

 

Gerald Commissiong, CEO of Amarantus BioScience Holdings, Inc. (OTCQX: AMBS) chats with Bob Power, OTC Markets VP of Corporate Services
Mar. 18, 2016

 
SNNLive with Amarantus Bioscience Holdings, Inc. (OTCQX: AMBS)  
December 2015


 

ESS Patients: Dr. Ahrenholz Interview Part 1 
 

ESS vs the Competition: Dr. Ahrenholz Interview Part 2

The Need for ESS: Dr. Ahrenholz Interview Part 3
 
 
 

 
                                                                                                                
 
 
    
       
 


                                                               Contact Information

Amarantus BioScience Holdings, Inc.
655 Montgomery Street
Suite 900
San Francisco, CA 94111

 

c/o ICS Corporate Services SA
29 quai du Mont Blanc
CH-1201 Geneva
Switzerland












 

[email protected]
[email protected]


Phone: (415) 688-4484
Fax: (408) 852-4427


Gerald's email address
[email protected]



IR Calendar 






 

INVESTOR RELATIONS

Jenene Thomas Communications
Jenene Thomas
T: 908-938-1475

[email protected]


 

TRANSFER AGENT

 

 
 
                                                                            

 

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
AMBS
Current Price
Volume:
Bid Ask Day's Range
SureTrader
AMBS News: Current Report Filing (8-k) 11/08/2016 05:03:18 PM
AMBS News: Current Report Filing (8-k) 10/27/2016 05:20:06 PM
AMBS News: Proxy Soliciting Materials (revised) (prer14a) 10/07/2016 05:09:15 PM
AMBS News: Current Report Filing (8-k) 10/06/2016 05:20:16 PM
AMBS News: Proxy Soliciting Materials (revised) (prer14a) 09/09/2016 05:24:57 PM
PostSubject
#125884   Posted By: IntlInfusion - financier of AMBS JPetroInc 02/24/17 02:07:01 PM
#125883   so buy now - before it runs away JPetroInc 02/24/17 11:58:11 AM
#125882   What ? It's up myersvodka 02/24/17 11:40:59 AM
#125881   dilution - dilution - dilution JPetroInc 02/24/17 09:43:31 AM
#125880   back to $0.025 again today JPetroInc 02/23/17 02:04:40 PM
#125879   say wat? JPetroInc 02/23/17 06:36:44 AM
#125878   Say what? It's been around .024 not to myersvodka 02/22/17 09:55:40 PM
#125877   dumpfest continues at $0.032's JPetroInc 02/22/17 09:51:52 AM
#125876   the Astoria Queens financial mafia won't let a JPetroInc 02/22/17 08:58:56 AM
#125874   There is no there, there, there isn't even joboggi 02/22/17 05:29:33 AM
#125873   Paula Trzepacz was on Amarantus's Scientific Advisory Board JPetroInc 02/21/17 09:17:54 PM
#125872   NEUROTROPE INC newflow 02/21/17 08:02:00 PM
#125871   what AMBS? JPetroInc 02/21/17 06:38:21 AM
#125870   Would you be happy if something good happens myersvodka 02/20/17 07:41:02 PM
#125869   Is it too late to buy in? Jumpinjackas 02/20/17 05:42:39 PM
#125868   what approval? JPetroInc 02/20/17 10:54:28 AM
#125867   So what happen with the approval and the vouchers?????? leslunier 02/20/17 07:49:46 AM
#125866   Amarantus BioScience's (AMBS) CEO Gerald Commissiong Hosts Business JPetroInc 02/19/17 11:43:46 AM
#125865   Multi-Billion Dollar Tissue Engineered Skin Substitutes Market Expected JPetroInc 02/19/17 11:34:42 AM
#125863   if dilution is off the table, how's the JPetroInc 02/19/17 10:50:23 AM
#125861   According to court filings on SCROLL Sason, Magna freegriff 02/18/17 08:38:34 PM
#125860   lawyers gathering like vulchers on the dead-ass lying JPetroInc 02/16/17 07:46:04 AM
#125859   1 to 100 tweet also got got removed....lol...scared? newflow 02/15/17 02:58:03 PM
#125858   AMBS IP is worth money JPetroInc 02/15/17 01:05:16 PM
#125857   lol ah I see, couldn't have said it StockWhale 02/15/17 10:23:53 AM
#125856   That's a curious thing I've questioned over the jugs 02/15/17 10:22:54 AM
#125855   Yes he did, but I still wanna know StockWhale 02/15/17 09:17:41 AM
#125854   Gerald, CEO - a chronic habitual LIAR JPetroInc 02/15/17 09:07:34 AM
#125853   Nice! So is this scam finally toast now??? StockWhale 02/14/17 11:56:40 PM
#125852   I hope they sue his arse for making JPetroInc 02/14/17 07:54:09 PM
#125851   GC deleted his "Wrong" tweet newflow 02/14/17 02:58:52 PM
#125850   long story here JPetroInc 02/14/17 12:37:50 PM
#125849   Wow .03 27times 02/14/17 10:57:57 AM
#125848   that 1.4-Mil. share bidder at $0.028 just up JPetroInc 02/13/17 02:29:13 PM
#125847   Yes, the cost of a startup bio tech myersvodka 02/11/17 08:57:42 PM
#125846   A good inventor not necessarily mean a good newflow 02/11/17 06:59:01 PM
#125845   can't make this stuff up JPetroInc 02/11/17 08:50:29 AM
#125844   what company? JPetroInc 02/11/17 08:45:37 AM
#125843   The first PR in 6 months is about Deputy123 02/11/17 05:10:02 AM
#125842   In a message dated 2/10/2017 8:59:59 P.M. Eastern JPetroInc 02/10/17 09:06:41 PM
#125841   compelling words from John Commissiong JPetroInc 02/10/17 08:33:07 PM
#125840   John Commissiong - now taking lead on PR's JPetroInc 02/10/17 01:08:45 PM
#125839   agreed again... JPetroInc 02/10/17 12:14:02 PM
#125838   agreed ESS was just a short term remedy (3 JPetroInc 02/10/17 12:06:43 PM
#125836   Not to say their isn't value in the jason_luke 02/10/17 09:27:41 AM
#125835   Nice to see AMBS recognize the good doctor's jason_luke 02/10/17 09:21:33 AM
#125834   Dr Joe Rubinfeld told the ASM shareholders in JPetroInc 02/10/17 09:12:35 AM
#125833   Probably died from embarrassment from being involved with AMBS. a surfer 02/10/17 09:01:13 AM
#125832   Amarantus Announces Passing of Biotechnology Legend Dr. Joseph Rubinfeld a surfer 02/10/17 08:58:40 AM
#125831   there is a 'higher' purpose Jugs JPetroInc 02/09/17 08:19:23 PM
PostSubject